CLASS II Device recall · Reported 10 Feb 2021 · FDA Enforcement Report
Sars-CoV-2 Antigen Test recalled by Qiagen Sciences
Qiagen Sciences is recalling Sars-CoV-2 Antigen Test, distributed in 19 states. The recall was initiated on 15 Jan 2021 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-0941-2021
- FDA event ID
- 87205
- Recalling firm
- Qiagen Sciences, Germantown, MD
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 15 Jan 2021
- FDA classified
- 31 Jan 2021
- Reported
- 10 Feb 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Other
- Reason category
- Other Reasons
- Device type
- Test Kits & Diagnostics
Timeline
| 15 Jan 2021 | Recall initiated by company | |
| 31 Jan 2021 | Classified by FDA | +16 days |
| 10 Feb 2021 | Published in enforcement report | +10 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
QIAGEN has become aware of the potential for false positive results to occur with some patient samples.
Product as listed by the FDA
SARS-CoV-2 Antigen Test
Where it was distributed
Domestic: AZ, CA, DC, CO,FL,HI, IL, KY, MI, MO, NC, NJ, NM, NY, OH, RI, TX, WA, WY
ArizonaCaliforniaColoradoDistrict of ColumbiaFloridaHawaiiIllinoisKentuckyMichiganMissouriNorth CarolinaNew JerseyNew MexicoNew YorkOhioRhode IslandTexasWashingtonWyoming
Questions about this recall
Why was it recalled?
QIAGEN has become aware of the potential for false positive results to occur with some patient samples.
Which lots are affected?
GTIN: 04053228039785, Catalog #: 646533, Lot #: 86651, 86652, 86653, 86654, 86659.
Where was it sold?
Domestic: AZ, CA, DC, CO,FL,HI, IL, KY, MI, MO, NC, NJ, NM, NY, OH, RI, TX, WA, WY
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Qiagen Sciences
All 23| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | QIAstat-Dx Respiratory Panel Plus Reference Number recalled | Qiagen Sciences | Device Malfunction | 12 states |
| Device | CLASS II | QIAcube Connect MDx - IVD Instrument designed to perform recalled | Qiagen Sciences | Potency & Assay | Nationwide |
| Device | CLASS II | EZ2 Connect MDx-IVD Designed to perform automated isolation recalled | Qiagen Sciences | Temperature Abuse | Nationwide |
| Device | CLASS II | QIAstat-Dx Respiratory Sars-CoV-2 Panel multiplexed nucleic recalled | Qiagen Sciences | Other | Nationwide |
| Device | CLASS II | QIAcube Connect MDx recalled by Qiagen Sciences | Qiagen Sciences | Other | 26 states |
Other Test Kits & Diagnostics recalls
All 2,675| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Nextseq 550Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | NovaSeq 6000Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | Liaison Plex Gram-Negative Blood Culture Assay recalled by Luminex | Luminex | Potency & Assay | Nationwide |
| Device | CLASS II | MiSeq Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | Techno-Path Multichem AE Unassayed Level recalled | Techno-path Manufacturing | Potency & Assay | Nationwide |